Neuregulin-1 protects against acute optic nerve injury in rat model

被引:3
|
作者
Yang, Wei [1 ]
Liu, Tao-Tao [1 ]
Song, Xiao-Bin [2 ]
Zhang, Yan [3 ]
Li, Zhao-Hui [4 ]
Hao, Qian [1 ]
Cui, Zhi-Hua [1 ]
Liu, Hong Lei [1 ]
Lei, Chun Ling [1 ]
Liu, Jun [1 ]
机构
[1] Jilin Univ, Dept Ophthalmol, Hosp 1, Changchun 130021, Peoples R China
[2] Jilin Prov Peoples Hosp, Dept Emergency Surg, Changchun 130021, Peoples R China
[3] Jilin Univ, Hosp 1, Dept Otorhinolaryngol Head & Neck Surg, Changchun 130021, Peoples R China
[4] Peoples Hosp Changchun City, Dept Ophthalmol, Changchun 130021, Peoples R China
关键词
Neuregulin-1; Optic nerve injury; Neuroprotective effects; Apoptosis; RETINAL GANGLION-CELLS; COHERENCE TOMOGRAPHY; AXONAL REGENERATION; EXPRESSION; SURVIVAL; GLAUCOMA;
D O I
10.1016/j.jns.2015.07.023
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: In this study, we employed a rat model and examined the expression pattern of neuregulin-1 (NRG-1) in optic nerve and retinal ganglion cells (RGCs) in response to optic nerve injury to understand the role of NRG-1 in conferring protection against acute optic nerve injury. Method: Forty-eight male rats were randomly divided into two groups, the sham-operation group (n = 24) and optic nerve injury group (n = 24). Flash visual evoked potentials (FVEP) and fundography images were acquired at different time points following optic nerve injury (2 h, 1 d, 2 d, 7 d, 14d and 28 d). Semi-quantitative analysis of NGR-1 expression pattern was performed by immunohistochemistry (IHC) staining. In a related experiment, 100 male rats were randomly divided into NCR-1 treatment group (n = 60) (treated with increasing dose of NCR-1 at 0.5 mu g, 1 mu g and 3 mu g), normal saline (NS) group (n = 20) and negative control group (n = 20). Optic nerve injury was induced in all the animals and in situ cell death was measured by detecting the apoptosis rates using TUNEL assay. Results: Fundus photography results revealed no detectable differences between the sham-operation group and optic nerve injury group at 2 h, 1 d, 2 d and 7 d. However at 2 weeks, the optic discs turned pale in all animals in the optic nerve injury group. NRG-1 expression increased significantly at all time points in the optic nerve injury group (P < 0.05), compared to the sham-operation group, with NRG-1 expression peaking at 14 d and gradually declining by 28 d. Statistically significant differences in amplitude and latency of P100 wave were also detected between the optic nerve injury and sham-operation group (P < 0.05). In related experiment, compared to NS group, treatment with 1 mu g and 3 mu g of recombinant human NRG-1 resulted in statistically significant FVEP-P100 amplitude values (all P < 0.05). Further, compared to the NS group, ganglion cell apoptosis was dramatically reduced in the NRG-1 group at all time points and the reduction was statistically significant in 3 mu g NRG-1 treatment group at 7 d, 14 d and 28 d (all P < 0.05). Conclusion: Our results strongly suggest that NRG-1 is highly effective in preserving normal optic nerve function and is essential for tissue repair following optic nerve injury. Thus, NRG-1 expression confers protection against acute optic nerve injury in a dose-dependent manner. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:157 / 166
页数:10
相关论文
共 50 条
  • [1] Upregulated neuregulin-1 protects against optic nerve injury by regulating the RhoA/cofilin/F-actin axis
    Hao, Qian
    Zhang, Yan
    Li, Xiaohong
    Liang, Lingling
    Shi, Hui
    Cui, Zhihua
    Yang, Wei
    [J]. LIFE SCIENCES, 2021, 264
  • [2] Role of neuregulin-1 in peripheral nerve injury
    Kong, Zhengdong
    Zhang, Zhiying
    Lin, Haiyan
    Zhang, Chuansen
    [J]. NEURAL REGENERATION RESEARCH, 2010, 5 (14) : 1104 - 1108
  • [3] Role of neuregulin-1 in peripheral nerve injury
    Zhengdong Kong
    [J]. Neural Regeneration Research, 2010, 5 (14) : 1104 - 1108
  • [4] The role of neuregulin-1 in the response to nerve injury
    Fricker, Florence R.
    Bennett, David Lh
    [J]. FUTURE NEUROLOGY, 2011, 6 (06) : 809 - 822
  • [5] Inhibition of endoplasmic reticulum stress by neuregulin-1 protects against myocardial ischemia/reperfusion injury
    Fang, Shan-Juan
    Li, Peng-Yang
    Wang, Chun-Mei
    Xin, Yi
    Lu, Wei-Wei
    Zhang, Xiao-Xia
    Zuo, Song
    Ma, Chang-Sheng
    Tang, Chao-Shu
    Nie, Shao-Ping
    Qi, Yong-Fen
    [J]. PEPTIDES, 2017, 88 : 196 - 207
  • [6] Neuregulin-1 protects mouse cerebellum against oxidative stress and neuroinflammation
    Xu, Junping
    Hu, Chengliang
    Chen, Shuangxi
    Shen, Huifan
    Jiang, Qiong
    Huang, Peizhi
    Zhao, Weijiang
    [J]. BRAIN RESEARCH, 2017, 1670 : 32 - 43
  • [7] Neuregulin-1 is neuroprotective in a rat model of organophosphate-induced delayed neuronal injury
    Li, Yonggang
    Lein, Pamela J.
    Liu, Cuimei
    Bruun, Donald A.
    Giulivi, Cecilia
    Ford, Gregory D.
    Tewolde, Teclemichael
    Ross-Inta, Catherine
    Ford, Byron D.
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2012, 262 (02) : 194 - 204
  • [8] Neuregulin-1 inhibits neuroinflammatory responses in a rat model of organophosphate-nerve agent-induced delayed neuronal injury
    Li, Yonggang
    Lein, Pamela J.
    Ford, Gregory D.
    Liu, Cuimei
    Stovall, Kyndra C.
    White, Todd E.
    Bruun, Donald A.
    Tewolde, Teclemichael
    Gates, Alicia S.
    Distel, Timothy J.
    Surles-Zeigler, Monique C.
    Ford, Byron D.
    [J]. JOURNAL OF NEUROINFLAMMATION, 2015, 12
  • [9] Neuregulin-1 inhibits neuroinflammatory responses in a rat model of organophosphate-nerve agent-induced delayed neuronal injury
    Yonggang Li
    Pamela J Lein
    Gregory D Ford
    Cuimei Liu
    Kyndra C Stovall
    Todd E White
    Donald A Bruun
    Teclemichael Tewolde
    Alicia S Gates
    Timothy J Distel
    Monique C Surles-Zeigler
    Byron D Ford
    [J]. Journal of Neuroinflammation, 12
  • [10] Neuregulin-1, a microvascular endothelial-derived protein, protects against myocardial ischemia-reperfusion injury (Review)
    Lin, Yuhao
    Liu, Haiqiong
    Wang, Xianbao
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2020, 46 (03) : 925 - 935